戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 , robust response to MRKAd5/HIV with that to yellow fever vaccine.
2 nteers immunized with the highly efficacious yellow fever vaccine.
3 o adjuvanted vaccines or the live-attenuated yellow fever vaccine.
4                                          The yellow fever vaccine 17D (17D) is safe, and after a sing
5 oenvironment to the response to the licensed yellow fever vaccine 17D (YF-17D) in an African cohort.
6                          The live attenuated yellow fever vaccine 17D (YF-17D) is one of the most eff
7                          The live attenuated yellow fever vaccine 17D (YF-17D) is one of the most eff
8 viral Ab responses, following infection with yellow fever vaccine 17D strain.
9 ology contain the nonstructural genes of the yellow fever vaccine and the premembrane and envelope ge
10  IPV given alongside the measles-rubella and yellow fever vaccines at 9 months and when given as a fu
11                         Vaccination with the yellow fever vaccine causes a systemic acute viral infec
12 on of the population who had ever received a yellow fever vaccine for each second level administrativ
13                  Although a highly effective yellow fever vaccine has been available for more than se
14 ly dynamic in humans after subcutaneous live yellow fever vaccine immunization.
15  whole-virus, beta-propiolactone-inactivated yellow fever vaccine produced in Vero cell cultures and
16 ned to receive the IPV, measles-rubella, and yellow fever vaccines, singularly or in combination.
17 2)-expressing plasmid (EP rDNA plus pIL-12), yellow fever vaccine virus 17D (rYF17D), and recombinant
18                          The live-attenuated yellow fever vaccine virus 17D (YF17D) has many properti
19          We show that recombinant attenuated yellow fever vaccine virus 17D expressing simian immunod
20 eta production in response to CpG DNA or the yellow fever vaccine virus strain 17D.
21 -administration of IPV, measles-rubella, and yellow fever vaccines within the Expanded Programme on I
22                                          The yellow fever vaccine YF-17D is one of the most successfu
23                             For example, the yellow fever vaccine YF-17D, one of the most successful
24 d immune responses in humans vaccinated with yellow fever vaccine YF-17D.
25                                     The live yellow fever vaccine (YF-17D) offers a unique opportunit
26                                          The yellow fever vaccine (YFV) has been broadly used as a mo
27 dividuals immunized with the live attenuated yellow fever vaccine (YFV-17D) by sampling peripheral bl

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。